191 related articles for article (PubMed ID: 2464104)
1. Beta 1-adrenoceptor selectivity of single oral doses of bisoprolol and atenolol.
Chang PC; van Veen S; van der Krogt JA; Vermeij P; van Brummelen P
J Cardiovasc Pharmacol; 1988 Sep; 12(3):317-22. PubMed ID: 2464104
[TBL] [Abstract][Full Text] [Related]
2. Double-blind comparison of the beta 1-selectivity of single doses of bisoprolol and atenolol.
Chang PC; van Veen S; Vermeij P; van Brummelen P
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S58-60. PubMed ID: 2439799
[TBL] [Abstract][Full Text] [Related]
3. Cardiac and vascular beta-adrenoceptor-mediated responses before and during treatment with bisoprolol or atenolol.
Bolli P; Müller FB; Linder L; Ji BH; Bühler FR
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S61-4. PubMed ID: 2439800
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the beta1-selectivity of three beta1-selective beta-blockers.
Nuttall SL; Routledge HC; Kendall MJ
J Clin Pharm Ther; 2003 Jun; 28(3):179-86. PubMed ID: 12795776
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol.
McLeod AA; Brown JE; Kuhn C; Kitchell BB; Sedor FA; Williams RS; Shand DG
Circulation; 1983 May; 67(5):1076-84. PubMed ID: 6299612
[TBL] [Abstract][Full Text] [Related]
6. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
[TBL] [Abstract][Full Text] [Related]
7. Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy.
Wellstein A; Palm D; Belz GG; Butzer R; Polsak R; Pett B
Eur Heart J; 1987 Dec; 8 Suppl M():3-8. PubMed ID: 2897299
[TBL] [Abstract][Full Text] [Related]
8. Assessment of beta-1 selectivity of bisoprolol and atenolol by means of their influence on the lipolytic response to an infusion of terbutaline.
Kendall MJ; Akhlaghi S; Haffner CA
J Clin Pharm Ther; 1991 Feb; 16(1):25-9. PubMed ID: 1673971
[TBL] [Abstract][Full Text] [Related]
9. A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol.
Lipworth BJ; Irvine NA; McDevitt DG
Eur J Clin Pharmacol; 1991; 40(2):135-9. PubMed ID: 1676675
[TBL] [Abstract][Full Text] [Related]
10. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
Riddell JG; Shanks RG
Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
[TBL] [Abstract][Full Text] [Related]
11. The assessment of the beta-adrenoceptor blocking activity and cardioselectivity of Koe 3290 in normal subjects.
Pringle TH; McNeill AJ; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):581-9. PubMed ID: 2893635
[TBL] [Abstract][Full Text] [Related]
12. Effect of bisoprolol and atenolol on endurance exercise capacity in healthy men.
Vanhees L; Defoor JG; Schepers D; Lijnen P; Peeters BY; Lacante PH; Fagard RH
J Hypertens; 2000 Jan; 18(1):35-43. PubMed ID: 10678541
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the cardioselectivity of five beta-adrenoceptor blocking drugs.
Pringle TH; Riddell JG; Shanks RG
J Cardiovasc Pharmacol; 1987 Aug; 10(2):228-37. PubMed ID: 2441175
[TBL] [Abstract][Full Text] [Related]
14. Sympathetic innervation and beta-adrenoceptor profile of blood vessels in the posterior region of the rabbit knee joint.
Najafipour H; Ferrell WR
Exp Physiol; 1993 Sep; 78(5):625-37. PubMed ID: 7694600
[TBL] [Abstract][Full Text] [Related]
15. Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292.
Smith HJ; Halliday SE; Earl DC; Stribling D
J Pharmacol Exp Ther; 1983 Jul; 226(1):211-6. PubMed ID: 6134820
[TBL] [Abstract][Full Text] [Related]
16. Antagonistic effects of bisoprolol on several beta-adrenoceptor-mediated actions in anaesthetized cats.
Schliep HJ; Schulze E; Harting J; Haeusler G
Eur J Pharmacol; 1986 Apr; 123(2):253-61. PubMed ID: 3011461
[TBL] [Abstract][Full Text] [Related]
17. Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Arnold JM; O'Connor PC; Riddell JG; Harron DW; Shanks RG; McDevitt DG
Br J Clin Pharmacol; 1985 May; 19(5):619-30. PubMed ID: 2860915
[TBL] [Abstract][Full Text] [Related]
18. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG
Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
[TBL] [Abstract][Full Text] [Related]
19. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
Leopold G; Ungethüm W; Pabst J; Simane Z; Bühring KU; Wiemann H
Br J Clin Pharmacol; 1986 Sep; 22(3):293-300. PubMed ID: 2876722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]